Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.
Status:
Terminated
Trial end date:
2018-11-14
Target enrollment:
Participant gender:
Summary
The purpose of this multicenter randomized study is to compare the effectiveness and safety
of erlotinib and pemetrexed in the maintenance treatment of patients with advanced
non-squamous non-small cell lung cancer (NSCLC)